Related Experiment Videos
[Castleman disease]
Gerardo A Belletti1, Verónica Savio, Daniel Minoldo
1Servicio de Clínica Médica del Hospital Italiano Cba.
Revista De La Facultad De Ciencias Medicas (Cordoba, Argentina)
|October 11, 2005
Summary
Multicentric Castleman disease is a rare condition presenting with systemic symptoms and lymphadenopathy. Prompt diagnosis and corticosteroid treatment led to a significant clinical and biochemical response in this patient.
Area of Science:
- Internal Medicine
- Hematology
- Oncology
Background:
- Multicentric Castleman disease (MCD) is a rare lymphoproliferative disorder with significant systemic manifestations.
- It often presents with constitutional symptoms, lymphadenopathy, and laboratory abnormalities, mimicking other conditions.
Observation:
- A 66-year-old female presented with a year of asthenia, arthralgias, skin lesions, anemia, and elevated inflammatory markers.
- Physical examination revealed significant weight loss, anorexia, adenopathy, and altered consciousness.
- Biopsies confirmed a hyperplastic lymphoid process and neutrophilic vasculitis.
Findings:
- The patient was diagnosed with Multicentric Castleman disease after excluding other etiologies.
- Initial treatment with high-dose corticosteroids (1 mg/kg) resulted in a rapid and remarkable clinical and biochemical improvement.
- Disease relapse occurred upon steroid withdrawal, necessitating re-initiation of corticosteroid therapy with a favorable outcome.
Implications:
- MCD, though rare, should be considered in the differential diagnosis of patients with severe systemic illness, lymphadenopathy, and responsiveness to steroids.
- Corticosteroid therapy is a crucial treatment modality for MCD, offering significant symptom control and disease management.
- This case highlights the importance of early recognition and appropriate management of MCD for improved patient outcomes.